Skip to main navigation Skip to search Skip to main content

Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia

  • Sun Loo
  • , Nicola Potter
  • , Adam Ivey
  • , Jenny O'Nions
  • , Roderick Moon
  • , Jelena Jovanovic
  • , Chun Y. Fong
  • , Natasha S. Anstee
  • , Ing Soo Tiong
  • , Jad Othman
  • , Chong Chyn Chua
  • , Hanna Renshaw
  • , Robert Baker
  • , Shaun Fleming
  • , Nigel H. Russell
  • , David Ritchie
  • , Ashish Bajel
  • , Hsin An Hou
  • , Richard Dillon
  • , Andrew H. Wei

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Pretransplant detection of KMT2Ar measurable residual disease ≥0.001% by quantitative polymerase chain reaction was associated with significantly inferior posttransplant survival (2-year relapse-free survival 17% vs 59%; P = .001) and increased 2-year cumulative incidence of relapse (75% vs 25%, P = .0004).

Original languageEnglish
Pages (from-to)2554-2557
Number of pages4
JournalBlood
Volume144
Issue number24
DOIs
Publication statusPublished - 12 Dec 2024

Cite this